A61K 9/0024
Solid, semi-solid or solidifying implants, which are implanted or injected in body
Official title: {Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L)}
A61K9/0024 (Solid, semi-solid or solidifying implants, which are implanted or injected in body) appears on 3,485 US grants and 5,557 published applications in this corpus.
Search patents in A61K- Granted patents
- 3,485
- Published applications
- 5,557
- Assignees
- 2,056
- Inventors
- 8,438
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 11 | 0 |
| 1977 | 4 | 0 |
| 1978 | 3 | 0 |
| 1979 | 7 | 0 |
| 1980 | 6 | 0 |
| 1981 | 5 | 0 |
| 1982 | 8 | 0 |
| 1983 | 3 | 0 |
| 1984 | 4 | 0 |
| 1985 | 3 | 0 |
| 1986 | 4 | 0 |
| 1987 | 8 | 0 |
| 1988 | 11 | 0 |
| 1989 | 10 | 0 |
| 1990 | 22 | 0 |
| 1991 | 18 | 0 |
| 1992 | 22 | 0 |
| 1993 | 13 | 0 |
| 1994 | 30 | 0 |
| 1995 | 21 | 0 |
| 1996 | 26 | 0 |
| 1997 | 54 | 0 |
| 1998 | 71 | 0 |
| 1999 | 78 | 0 |
| 2000 | 47 | 0 |
| 2001 | 72 | 26 |
| 2002 | 70 | 115 |
| 2003 | 65 | 157 |
| 2004 | 59 | 178 |
| 2005 | 49 | 179 |
| 2006 | 73 | 208 |
| 2007 | 49 | 193 |
| 2008 | 42 | 214 |
| 2009 | 34 | 216 |
| 2010 | 102 | 228 |
| 2011 | 99 | 245 |
| 2012 | 141 | 222 |
| 2013 | 180 | 230 |
| 2014 | 204 | 240 |
| 2015 | 197 | 232 |
| 2016 | 164 | 239 |
| 2017 | 173 | 249 |
| 2018 | 148 | 216 |
| 2019 | 165 | 262 |
| 2020 | 141 | 272 |
| 2021 | 155 | 277 |
| 2022 | 129 | 271 |
| 2023 | 127 | 271 |
| 2024 | 118 | 218 |
| 2025 | 154 | 236 |
| 2026 | 86 | 163 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Implantable depots for localized, sustained, controlled release of therapeutic agents to treat cancer and related conditions29 Sep 2026US 12,746,222 B2Foundry Therapeutics, Inc.
- Treatment of inflammatory diseases of the central nervous system29 Sep 2026US 12,746,245 B2Palmaya Pty Ltd
- Implants for release of lipophilic or amphiphilic pharmaceutical substances29 Sep 2026US 12,746,275 B2ReacX Pharmaceuticals, Inc.
- Use of phthalide compounds in treatment of meningioma22 Sep 2026US 12,740,964 B2Everfront Biotech Inc.
- Progesterone formulation to trigger ovulation and provide luteal phase support15 Sep 2026US 12,734,179 B2Augusta University Research Institute, Inc.
- Hyaluronic acid hydrogels with agent to enhance resorption8 Oct 2026US 2026/0306398 A1Boston Scientific Scimed, Inc.
- Subcutaneous peptide delivery system8 Oct 2026US 2026/0306408 A1
- Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse8 Oct 2026US 2026/0308532 A1Fred Hutchinson Cancer Center
- Sensor for analyte monitoring with drug-eluting capabilities1 Oct 2026US 2026/0294292 A1Senseonics, Incorporated
- Hyaluronic acid-based gels including lidocaine24 Sep 2026US 2026/0284270 A1Allergan Industrie, SAS
Most cited
By later US patents
- Closed porous chambers for implanting tissue in a host1,958US 5,344,454 ABaxter International Inc. · 1994
- Surgical implant and method for controlled release of chemotherapeutic agents1,679US 5,290,271 A1994
- Drug releasing biodegradable fiber implant1,662US 6,596,296 B1Board of Regents, The University of Texas System · 2003
- Renewable neural implant device and method1,456US 5,554,148 ABrown University Research Foundation · 1996
- Injectable microdispersions for soft tissue repair and augmentation1,443US 5,599,852 AEthicon, Inc. · 1997